Cambridge, MA, United States of America

Christophe Chantre

This inventor holds 2 USPTO granted patents. Top assignee: Harvard College. Active years: 2020-2026.


% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Christophe Chantre

Introduction

Christophe Chantre is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of devices that support the growth of muscle tissue.

Latest Patents

Chantre holds a patent for "Anisotropic muscular tissue devices with integrated electrical force readouts." This invention focuses on devices designed to support the growth of anisotropic muscle tissue layers. The patent describes methods for in vitro readout and quantification of the force generated by these tissue layers using integrated strain-sensing elements. Additionally, it includes multiplexed apparatuses of multiple independent devices, methods of fabricating these devices, and methods of utilizing them effectively.

Career Highlights

Chantre is affiliated with Harvard College, where he continues to advance research in tissue engineering and related fields. His work has garnered attention for its innovative approach to understanding and measuring muscle tissue behavior.

Collaborations

Chantre has collaborated with notable researchers, including Kevin Kit Parker and Johan Ulrik Lind. Their combined expertise has contributed to the advancement of technologies in the biomedical sector.

Conclusion

Christophe Chantre's work exemplifies the intersection of innovation and practical application in the field of biomedical engineering. His contributions are paving the way for future advancements in tissue engineering and muscle research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…